BIOMARIN PHARMACEUTICAL INC (BMRN)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading BIOMARIN PHARMACEUTICAL INC chart...

About the Company

We do not have any company description for BIOMARIN PHARMACEUTICAL INC at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

2581

Exchange

Nasdaq

$373M

Total Revenue

3K

Employees

$17B

Market Capitalization

100.54

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $BMRN News

Elliott Waives BioMarin Board Deal, Quashing Lawsuit

2d ago, source: usaherald

In a dramatic shift in corporate strategy, Elliott Investment Management LP has relinquished an earlier pact with BioMarin ...

Biomarin Pharmaceutical Inc BMRN

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?

2d ago, source: Zacks.com on MSN

BioMarin Pharmaceutical (BMRN) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2024. This widely-known ...

Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations

3d ago, source:

Wells Fargo analyst Mohit Bansal has maintained their bullish stance on BMRN stock, giving a Buy rating on April 12. Mohit Bansal has given ...

Jim Cramer's Five Best Stock Picks for the Biotech Sector

9y ago, source: TheStreet.com

TheStreet Ratings team rates BIOMARIN PHARMACEUTICAL INC as a Hold with a ratings score of C-. TheStreet Ratings Team has this to say about their recommendation: "We rate BIOMARIN PHARMACEUTICAL ...

Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...

7d ago, source:

Biomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and commercializing ...

BioMarin Pharmaceutical Inc.

3y ago, source: CNN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products ...

BioMarin Pharmaceutical Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BioMarin Pharmaceutical Inc. (BMRN)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...